Financial News
All News about Supernus Pharm
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
October 09, 2023
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
Via Benzinga
Supernus Pharmaceuticals's Earnings: A Preview
May 08, 2023
Via Benzinga
Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms
September 09, 2023
Via GlobeNewswire
Supernus to Participate in the Wells Fargo Healthcare Conference
August 31, 2023
Via GlobeNewswire
Bethany L. Sensenig Joins Supernus’ Board of Directors
August 21, 2023
Via GlobeNewswire
Supernus Announces Second Quarter 2023 Financial Results
August 08, 2023
Via GlobeNewswire
Supernus Announces Repayment of Convertible Notes
April 03, 2023
Via GlobeNewswire
Supernus to Participate in Two Upcoming Investor Conferences
March 08, 2023
Via GlobeNewswire
Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
Via GlobeNewswire
Supernus Enters Into $150 Million Credit Facility
February 14, 2023
Via GlobeNewswire
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.